Semaglutide
€179.00
Productinformation
3ml cartridge with 2mg semaglutide
Expiration date: 01-10-2027
Pen delivers doses of 0.25 or 0.5mg.
3ml cartridge with 5mg semaglutide
Expiration date: 01-10-2027
Pen delivers doses of 0.25 0.5, 0.75, 1 or 1.25mg
Keep in the fridge between 3 and 7 °C.
Use only 8 weeks after first dose.
Dosing schedule
The dosing regimen for semaglutide for weight loss typically involves a gradual increase in dosage to minimize side effects and allow the body to adjust to the medication. Here's a general outline of the dosing regimen for semaglutide for weight loss:
Starting Dose: The usual starting dose of semaglutide for weight loss is 0.25 mg once weekly. This lower dose helps to minimize gastrointestinal side effects, such as nausea, which can occur when starting the medication.
Week-by-Week Increase: After starting with the initial dose of 0.25 mg once weekly, the dosage is gradually increased on a weekly basis over several weeks. The dose is typically increased in increments of 0.25 mg per week until the target dose is reached.
Target Dose: The target dose of semaglutide for weight loss is 2.4 mg once weekly. This is the maintenance dose that is recommended for achieving optimal weight loss benefits.
Semaglutide is a groundbreaking treatment for obesity, developed as a GLP-1 receptor agonist. It works by activating receptors in the brain and gut, increasing insulin secretion, reducing appetite, and slowing gastric emptying—leading to reduced calorie intake and weight loss.
Clinical trials have shown significant results, with an average weight loss of 14.9% over 68 weeks, compared to 2.4% with placebo. Preclinical and neuroimaging studies confirm its impact on appetite control and energy balance.
Semaglutide also improves cardiometabolic health, reducing blood pressure, cholesterol, and inflammation. By targeting underlying metabolic dysfunctions like insulin resistance, it offers a comprehensive approach to obesity management.
Real-world evidence supports its long-term effectiveness and safety across diverse populations, positioning semaglutide as a promising, scientifically validated solution to the global obesity epidemic.
The pen comes with a clear instruction flyer. According to our customers, this makes the pen easy to use.
Weight Loss Pen Europe GmbH
Biocampus München
82152 Martinsried
Germany